// App-Quantinova.ai

4647 : BET protein inhibition blocks growth of triple-negative breast cancer by inducing mitotic and cytokinetic dysfunction

Researchers

Presenter

  • Jennifer M. Brancato

Principal Investigators

  • Sylvia Gayle

  • Kristen Weber-Bonk

  • Matthew Summers

  • Gurkan Bebek

  • Ruth Keri

Medical Centers

  • Case Western Reserve University, Cleveland, OH

  • Cleveland Clinic, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Congestive heart failure

  • Solid malignancies

Biomarkers

  • cMYC

Drug/Treatment

  • AZD-1152

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved